FDA Recalls Blood Pressure Medication Due to Potential Contamination
The Food and Drug Administration (FDA) has issued a recall for a popular blood pressure medication, bisoprolol fumarate and hydrochlorothiazide tablets, marketed under the brand name Ziac. The recall was prompted by the discovery of potential cross-contamination with ezetimibe, a cholesterol-lowering drug, during testing of reserve samples. The affected tablets, produced by Madhya Pradesh in India for Glenmark Pharmaceuticals, include various dosages ranging from 2.5 mg to 6.25 mg. The recall involves over 11,100 bottles, with specific lot numbers and expiration dates provided. This recall is classified as Class III, indicating that the use of the product is not likely to cause adverse health consequences. Bisoprolol fumarate is a beta-blocker that helps the heart beat normally, while hydrochlorothiazide is a diuretic that helps lower blood pressure by removing excess sodium and water from the body. 
